Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$125.91 - $144.34 $4.08 Million - $4.68 Million
32,389 New
32,389 $4.43 Million
Q3 2022

Nov 14, 2022

SELL
$121.77 - $141.1 $564,525 - $654,139
-4,636 Reduced 23.72%
14,907 $1.83 Million
Q2 2022

Aug 15, 2022

BUY
$127.07 - $145.39 $1.48 Million - $1.69 Million
11,630 Added 146.97%
19,543 $2.6 Million
Q1 2022

May 16, 2022

BUY
$129.09 - $164.35 $603,624 - $768,500
4,676 Added 144.45%
7,913 $1.08 Million
Q4 2021

Feb 14, 2022

SELL
$140.36 - $173.01 $595,968 - $734,600
-4,246 Reduced 56.74%
3,237 $560,000
Q3 2021

Nov 15, 2021

SELL
$132.95 - $158.0 $662,356 - $787,156
-4,982 Reduced 39.97%
7,483 $1.09 Million
Q2 2021

Aug 16, 2021

BUY
$126.66 - $141.48 $18,745 - $20,939
148 Added 1.2%
12,465 $1.65 Million
Q1 2021

May 17, 2021

BUY
$114.63 - $133.34 $1.41 Million - $1.64 Million
12,317 New
12,317 $1.58 Million
Q4 2020

Feb 16, 2021

SELL
$112.7 - $128.05 $224,611 - $255,203
-1,993 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$107.05 - $130.01 $213,350 - $259,109
1,993 New
1,993 $228,000
Q2 2020

Aug 14, 2020

SELL
$73.34 - $122.61 $10,047 - $16,797
-137 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$75.14 - $115.68 $33,061 - $50,899
-440 Reduced 76.26%
137 $11,000
Q4 2019

Feb 14, 2020

BUY
$100.29 - $107.99 $57,867 - $62,310
577 New
577 $62,000
Q3 2018

Nov 14, 2018

SELL
$105.42 - $114.99 $79,170 - $86,357
-751 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$97.35 - $113.14 $58,799 - $68,336
-604 Reduced 44.58%
751 $83,000
Q1 2018

May 15, 2018

BUY
$96.42 - $107.88 $41,749 - $46,712
433 Added 46.96%
1,355 $136,000
Q4 2017

Feb 14, 2018

BUY
$90.86 - $100.24 $83,772 - $92,421
922
922 $91,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.